Bayesian Capital Management’s Unilever NV New York Registry Shares UN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,582
Closed -$663K 909
2020
Q1
$663K Buy
+13,582
New +$743K 0.14% 217
2019
Q3
Sell
-4,081
Closed -$248K 772
2019
Q2
$248K Buy
+4,081
New +$244K 0.05% 404
2018
Q4
Sell
-6,495
Closed -$361K 879
2018
Q3
$361K Buy
+6,495
New +$368K 0.06% 407
2017
Q4
Sell
-15,046
Closed -$888K 833
2017
Q3
$888K Buy
+15,046
New +$878K 0.21% 147
2016
Q2
Sell
-5,412
Closed -$242K 635
2016
Q1
$242K Buy
+5,412
New +$233K 0.23% 227

Other funds holding UN

Bayesian Capital Management's UN Position: Q2 2020 in Review

Bayesian Capital Management sold out of Unilever NV New York Registry Shares (UN) in Q2 2020, closing a stake of 13,582 shares — an estimated $663K sold.

Bayesian Capital Management first reported a position in UN in Q1 2016 and held it in 5 quarters. The position peaked at $888K in Q3 2017. 605 funds tracked by Wall St. Rank hold UN as of Q2 2020.

  • Bayesian Capital Management reported no remaining Unilever NV New York Registry Shares position as of Q2 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 13,582 Unilever NV New York Registry Shares shares in Q2 2020, an estimated $663K.
  • Bayesian Capital Management first reported a position in Unilever NV New York Registry Shares in Q1 2016 and held it in 5 quarters.
  • Bayesian Capital Management's Unilever NV New York Registry Shares position peaked at $888K in Q3 2017.
  • 605 funds tracked by Wall St. Rank held Unilever NV New York Registry Shares as of Q2 2020.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.